An enzyme in macrophage immune cells may be a good target for treating chronic infections, Vanderbilt researchers have discovered.

The compound MPLA is an attractive vaccine component, designed to elicit a robust immune response.

A new method will make it possible to study solid tumors and healthy tissues using mass cytometry.

A new method developed at Vanderbilt will speed the search for potential therapeutics for diabetes: compounds that stimulate the replication of insulin-producing beta cells.

Vanderbilt researchers have made the surprising discovery that the protease plasmin, known for its clot-busting role in the blood, protects soft tissue from turning to bone after severe injuries and certain orthopaedic surgeries.

A novel drug that targets the protein RSK blocked aggressive breast cancers from metastasizing in an animal model.

Blood-forming stem cells play a role in immune tolerance and acceptance of organ transplants, Vanderbilt researchers have discovered.